Cargando…
Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262875/ https://www.ncbi.nlm.nih.gov/pubmed/35798701 http://dx.doi.org/10.1038/s41467-022-30946-9 |
| _version_ | 1784742593572110336 |
|---|---|
| author | Kumar, Sushil Nandi, Ajeya Singh, Snahlata Regulapati, Rohan Li, Ning Tobias, John W. Siebel, Christian W. Blanco, Mario Andres Klein-Szanto, Andres J. Lengner, Christopher Welm, Alana L. Kang, Yibin Chakrabarti, Rumela |
| author_facet | Kumar, Sushil Nandi, Ajeya Singh, Snahlata Regulapati, Rohan Li, Ning Tobias, John W. Siebel, Christian W. Blanco, Mario Andres Klein-Szanto, Andres J. Lengner, Christopher Welm, Alana L. Kang, Yibin Chakrabarti, Rumela |
| author_sort | Kumar, Sushil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9262875 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92628752022-07-09 Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway Kumar, Sushil Nandi, Ajeya Singh, Snahlata Regulapati, Rohan Li, Ning Tobias, John W. Siebel, Christian W. Blanco, Mario Andres Klein-Szanto, Andres J. Lengner, Christopher Welm, Alana L. Kang, Yibin Chakrabarti, Rumela Nat Commun Author Correction Nature Publishing Group UK 2022-07-07 /pmc/articles/PMC9262875/ /pubmed/35798701 http://dx.doi.org/10.1038/s41467-022-30946-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Kumar, Sushil Nandi, Ajeya Singh, Snahlata Regulapati, Rohan Li, Ning Tobias, John W. Siebel, Christian W. Blanco, Mario Andres Klein-Szanto, Andres J. Lengner, Christopher Welm, Alana L. Kang, Yibin Chakrabarti, Rumela Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway |
| title | Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway |
| title_full | Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway |
| title_fullStr | Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway |
| title_full_unstemmed | Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway |
| title_short | Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway |
| title_sort | author correction: dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through nf-κb survival pathway |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262875/ https://www.ncbi.nlm.nih.gov/pubmed/35798701 http://dx.doi.org/10.1038/s41467-022-30946-9 |
| work_keys_str_mv | AT kumarsushil authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT nandiajeya authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT singhsnahlata authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT regulapatirohan authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT lining authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT tobiasjohnw authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT siebelchristianw authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT blancomarioandres authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT kleinszantoandresj authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT lengnerchristopher authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT welmalanal authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT kangyibin authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway AT chakrabartirumela authorcorrectiondll1quiescenttumorstemcellsdrivechemoresistanceinbreastcancerthroughnfkbsurvivalpathway |